4-(4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)-2-methylnicotinonitrile, 95.0%, 1g

5-HYDROXY-7-METHYL-1H-INDAZOLE, 97%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((3-methylpentan-3-yl)oxy)-4-oxobutanoic acid, 97%, 10g

(2-CHLORO-PHENYL)-DIMETHYLAMINO-ACETIC ACID HCL, 95.0%, 250mg

2,2-Dimethyl-1,3-cyclohexanedione, 95.0%, 5g

N-(5-Fluoro-2-methylphenyl)-4-methylbenzenesulfonamide, 97%, 1g

3-BROMO-2-METHOXYPHENOL, 95.0%, 250mg

Conjunto de contraste de fases Zernike PLPH 10/20/40/100 posición de campo claro y campo oscuro

4-Ethoxycinnamic Acid>98.0%(GC)(T)25g

Dichlorodiphenylsilane>98.0%(GC)500g

1,2,4-Triaminobenzene Dihydrochloride>95.0%(N)(T)1g

5-Methyl-5-(4-methylphenyl)imidazolidine-2,4-dione, 97%, 250mg

Pyrimido[4,5-d]pyrimidin-4-amine, 95.0%, 1g